Navigation Links
WallSt.net Updates Investment Community Through All-New Interview With WiFiMed
Date:2/12/2008

NEW YORK, Feb. 12 /PRNewswire/ -- On February 11, Greg Vacca, CEO of WiFiMed Holdings Company, Inc. (OTC Bulletin Board: WIFM) updated the investment community in an all-new interview with http://www.wallst.net. Topics covered in the interview include an overview of the company and its growth strategy, recent press releases, market opportunity, and upcoming milestones for which investors should watch.

To hear the interview, visit http://www.wallst.net and click "Interviews." Locate the company's ticker symbol under the appropriate exchange at the top of the "Interviews" section of the site or enter the company's ticker symbol in the Search Archive window.

Ask Greg Vacca a question, post a comment on his personal page, and join his financial social network today at http://www.mywallst.net.

About WiFiMed Holdings:

WiFiMed Holdings Company, Inc., through its wholly owned subsidiaries WiFiMed, Inc. and EncounterPRO Healthcare Resources, Inc., offers proprietary solutions enabling physicians and other healthcare providers to document the physician-patient encounter through continuously updated state-of-the-art technologies. WiFiMed Inc.'s proprietary product, Tablet MD(R) and EncounterPRO Healthcare Resources, Inc.'s proprietary product, EncounterPRO(R) EHR, were developed to assist physicians and health care providers manage patient workflow. Tablet MD(R) operates on a tablet PC and manages patient medical information, consultation notes, prescriptions, records, and charts through five proprietary technologies. The EncounterPRO(R) EHR gives physicians and staff the most flexible and sophisticated workflow engine available in an EHR. This premier software requires virtually no level of computer literacy and works off touch screens, Tablet PCs or a mouse as the primary means of data input. Both products have been designed to meet the Health Insurance Portability and Accountability Act (HIPAA) requirements and are designed to reduce medical errors, documentation time, overhead, and time spent filing insurance claims.

About WallSt.net

http://www.wallst.net is owned and operated by WallStreet Direct, Inc., a wholly owned subsidiary of Financial Media Group, Inc. (http://www.financialmediagroupinc.com). The website is a leading provider of business news, executive interviews, multimedia content and research tools. Financial Media Group, Inc. owns http://www.mywallst.net, a financial social network for investors and Financial Filings Corp., a provider of compliance solutions to publicly traded companies. WallStreet Direct also owns and operates WallStRadio, a business and finance podcast website. Financial Filings Corp. is expecting to receive two hundred eighty dollars from WiFiMed Holdings Company, Inc. for the dissemination of this press release. For a complete list of our advertisers and advertising relationships, visit http://www.wallst.net/disclaimer/disclaimer.asp.

(Logo: http://www.newscom.com/cgi-bin/prnh/20050927/LATU121LOGO)

Contact: WallSt.net

800-4-WALLST


'/>"/>
SOURCE WallStreet Direct, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. WallSt.net Updates Investment Community Through All-New Interview With Transplant Creations
2. WallSt.net Announces Upcoming Interview With CEO of Avicena Group
3. WallSt.net Announces Upcoming Interview with CSO and COO of Urigen Pharmaceuticals
4. WallSt.net Announces Upcoming Interview With CEO of Alliance HealthCard
5. Skystar Bio-Pharmaceutical Announces Upcoming Interview With WallSt.net ( www.wallst.net )
6. WallSt.net (www.wallst.net) Updates the Investment Community Through All-New Interviews With XMDC, POSS and TYPE
7. WallSt.net Updates Investment Community Through All-New Interview With XTend Medical
8. WallSt.net Updates Investment Community Through All-New Interview With Ingen Technologies
9. Merrell Updates Performance Line with the Launch of OrthoLite Insoles
10. Matrixx Initiatives, Inc. Updates 2007/2008 Cold Season Trends and Fiscal 2008 Sales and Earnings Outlook
11. PPD Updates 2007 Forecast; Issues Financial Guidance for 2008
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/12/2017)... CA (PRWEB) , ... October 12, 2017 , ... ... Cheng, are now treating sleep apnea using cutting-edge Oventus O2Vent technology. ... a serious sleep disorder characterized by frequent cessation in breathing. Oral appliances can ...
(Date:10/12/2017)... ... October 12, 2017 , ... IsoComforter, Inc. ( https://isocomforter.com ... introduction of an innovative new design of the shoulder pad. The shoulder pad ... comfort while controlling your pain while using cold therapy. By utilizing ice and water ...
(Date:10/12/2017)... ... October 12, 2017 , ... Information ... we intend to develop to enable prevention of a major side effect of ... loss, especially in pediatric patients. For cisplatin, hearing loss is FDA listed on-label ...
(Date:10/12/2017)... ... 12, 2017 , ... Leading pediatric oncology experts at Children’s National Health ... Congress of the International Society of Paediatric Oncology (SIOP) Oct. 12-15. Chaired ... Cancer and Blood Disorders at Children’s National, and Stephen P. Hunger, M.D., Chief ...
(Date:10/12/2017)... ... October 12, 2017 , ... Health ... interactive health literacy software tool, and the Cancer Patient Education Network (CPEN), an ... education, today announce a new strategic alliance. , As CPEN’s strategic partner, ...
Breaking Medicine News(10 mins):
(Date:9/27/2017)... , Sept. 27, 2017  DarioHealth Corp. (NASDAQ: DRIO), a leading global ... that its MyDario product is expected to appear on The Dr. Oz ... Dr. Oz Show airs in your area: http://www.doctoroz.com/page/where-watch-dr-oz-show ... The nine-time Emmy award-winning, The Dr. Oz Show kicked ... The segment features ...
(Date:9/25/2017)... , Sept. 25, 2017  EpiVax, Inc., a ... design, and immune-engineering today announced the launch of ... development of personalized therapeutic cancer vaccines. EpiVax has ... exclusive access to enabling technologies to the new ... will lead EpiVax Oncology as Chief Executive Officer. ...
(Date:9/22/2017)... Sept. 22, 2017  As the latest Obamacare repeal ... Bill Cassidy (R-LA) and Lindsey Graham ... the medical device industry is in an odd place. ... the 2.3% excise tax on medical device sales passed ... want covered patients, increased visits and hospital customers with ...
Breaking Medicine Technology: